News

Ex-OpenAI science chief Kevin Weil launches Warp Sciences with $215M for drug chemistry

  • Duncan Riley--SiliconANGLE News
  • published date: 2026-10-22 22:08:24 UTC

Drug discovery chemistry startup Warp Sciences Inc. launched today with $215 million in new funding, six months after co-founder and Chief Executive Kevin Weil left his job running science initiatives at OpenAI Group PBC. Warp is building a chemistry contract…

Continue Reading at SiliconANGLE News →